NMS-P937

• Description:

  NMS-P937 (NMS1286937), an oral, specific Polo-like Kinase 1 (PLK1) inhibitor, is with IC50 of 2 nM. The specificity of NMS-P937 forPLK1 is 5000-fold higher over PLK2/PLK3.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  532.52

• Molecular Formula:

  C24H27F3N8O3

• Notes:

  Research use only, not for human use.

• Receptor:

  PLK1| PLK2| PLK3

• CAS Number:

  1034616-18-6